Articles by Camille Mojica Rey
-
Being A Multicultural Millennial Female In Pharma Manufacturing
6/1/2018
Tawni Koutchesfahani, director of manufacturing strategy at Relypsa, says pharmaceutical manufacturing must diversify if it is to thrive. That means the recruitment and retention of more women and more millennials.
-
J&J's QuickFire Challenges: Crowdsourcing Innovation
5/2/2018
An in-depth look at J&J’s QuickFire Challenge program and how some of the winners have benefitted (and grown) beyond the cash grants.
-
Pharmas That Build Unique Corporate Cultures
4/6/2018
Creating unique cultures that motivate your inherently diverse teams for the long haul to FDA approval is the secret to recruitment and retention in pharma where competition for highly skilled workers is fierce. It is also the key to achieving high performance and employee satisfaction.
-
The Art Of Leadership
2/7/2018
Former Pfizer exec and current partner at VC firm Polaris Partners Amy Schulman talks about what it takes to lead a pharma startup.
-
One Small Startup's Quest For Funding Gets Creative
1/9/2018
As CEO of Ensysce Biosciences, a semi-virtual company with three employees, Lynn Kirkpatrick, Ph.D., knows all about the funding struggles of a small company.
-
Will Value-Based Drug Pricing Work?
11/8/2017
Drug companies have begun experimenting with value-based models, largely in response to public outrage over the cost of prescription drugs and the U.S. government’s efforts to rein in those costs.
-
Diversification Relieves Funding Pressure For Small Pharma
10/10/2017
Chronic pressure is a way of life for those starting pharmaceutical companies. It’s a life filled with rounds of funding, investor demands, performance deadlines, and possible compound failures. But what if the technology owned by a startup drug discovery company was suddenly in demand by some of the world’s largest food and beverage corporations? What if that opportunity gives you the flexibility and time to conduct your research on your own timetable?
-
Value-Based Healthcare: Pharma's Role In The Transition
10/10/2017
This is the first in a two-part series on value-based healthcare. In Part II, Life Science Leader will look at value-based models used to determine the price of drugs.
-
Preparing For A Blockchain-Enabled World
9/8/2017
Ask life sciences industry leaders and experts about blockchain and you will hear it called everything from “a game changer” to “a major disrupter.” According to the hype, the technology behind cryptocurrencies, like bitcoin, is going to completely transform day-to-day operations for life sciences companies.
-
New Hampshire: A Biotech Microhub
8/9/2017
As the biotech sector in the U.S. continues to grow, it is doing so not just in hubs, but in smaller places like New Hampshire — where some of the state’s biopharma entrepreneurs say: “Smaller is better.”